New monitor aims to free diabetics from daily finger pricks
NCT ID NCT06904846
Summary
This study is testing a wearable device called the iCan O3 Continuous Glucose Monitoring (CGM) System. It aims to see if using the device for 60 days helps adults with type 1 or type 2 diabetes better manage their blood sugar levels. The study will measure if people spend more time in their target blood sugar range and how the device affects their daily life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UZA ANTWERP UZA Dienst Endocrinologie
Antwerp, Belgium
Conditions
Explore the condition pages connected to this study.